Acne Drugs Market Growth Trajectory Through 2024-2033

Spread the love

The Acne Drugs by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Acne Drugs Market:

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

According to The Business Research Company’s Acne Drugs, The acne drugs market size has grown steadily in recent years. It will grow from $5.84 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increase in acne prevalence, rising population, strong economic growth increase in pharmaceutical expenditure, rise in disposable income and increased healthcare expenditure.

The acne drugs market size is expected to see steady growth in the next few years. It will grow to $7.3 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to faster economic growth, rise in healthcare expenditure, high potential of emerging economies, increasing teenage population and sedentary lifestyles. Major trends in the forecast period include investing in narrow spectrum antibiotics, development of combination therapies for acne treatment, investing on cannabis products consisting cannabis oil, investing in partnerships to develop new drugs and using social media to market the acne treatment products.

An increase in the disposable income of people is one of the major drivers in the acne drug market. An increase in disposable income is usually due to an improved economy leading to increased wages and salaries and boosting healthcare expenditure. According to the Bureau of Economic Analysis, in July 2023, disposable personal income increased by $7.3 billion. The rise in disposable income and increased expenditure on facial care products is expected to continue, thereby driving the market in the forecast period.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=2412&type=smp

The acne drugs market covered in this report is segmented –

1) By Type: Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs

2) By Therapeutic Class: Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics

3) By End User: Hospitals & Clinics, Pharmacies & Drug Stores, Other End Users

Combination therapy is the latest trend in the acne drug market. Combination therapy is the process of combining two drugs with different mechanisms of action, such combinations of medication have better efficacy and adherence when compared with monotherapy (the use of only a single drug by itself). The combination of a topical retinoid drug, which unclogs the pores, along with an antimicrobial drug, which is used to treat an infection is being used to treat acne drugs. Example of combination therapy includes Epiduo, Acanya, Ziana, and Benzamycin produced by Galderma, Allergan, Medicis, and Atrix respectively.

The acne drugs market report table of contents includes: